. Author manuscript; available in PMC: 2013 Nov 11.

Published in final edited form as: Clin Pharmacol Ther. 2011 May 4;89(6):867–874. doi: 10.1038/clpt.2011.47

Table 4.

P values for the regression of Principal Component 3 against various demographic variables, formatted as described in Table 2

Variable	All	CBZ	Control	VPA
Group	0.0239	-	-	-
Age	0.7877	0.5544	0.2582	0.8455
Gender	0.3792	0.0640	0.2715	0.9151
Race	0.6321	0.4677	0.6304	0.9294
Weight	0.9032	0.4108	0.6008	0.5823
Dose	0.7792	0.5114	-	0.5942
Concurrent Medications	-	-	-	0.0057